121 related articles for article (PubMed ID: 7674830)
1. Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells.
Akunne HC; Towers P; Ellis GJ; Dijkstra D; Wikström H; Heffner TG; Wise LD; Pugsley TA
Life Sci; 1995; 57(15):1401-10. PubMed ID: 7674830
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
4. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
Mierau J; Schneider FJ; Ensinger HA; Chio CL; Lajiness ME; Huff RM
Eur J Pharmacol; 1995 Jun; 290(1):29-36. PubMed ID: 7664822
[TBL] [Abstract][Full Text] [Related]
5. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
Gonzalez AM; Sibley DR
Eur J Pharmacol; 1995 Jan; 272(1):R1-3. PubMed ID: 7713138
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.
Hall H; Halldin C; Dijkstra D; Wikström H; Wise LD; Pugsley TA; Sokoloff P; Pauli S; Farde L; Sedvall G
Psychopharmacology (Berl); 1996 Dec; 128(3):240-7. PubMed ID: 8972543
[TBL] [Abstract][Full Text] [Related]
7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.
Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK
J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.
Vessotskie JM; Kung MP; Chumpradit S; Kung HF
Neuropharmacology; 1997 Jul; 36(7):999-1007. PubMed ID: 9257944
[TBL] [Abstract][Full Text] [Related]
10. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
Whetzel SZ; Shih YH; Georgic LM; Akunne HC; Pugsley TA
J Neurochem; 1997 Dec; 69(6):2363-8. PubMed ID: 9375667
[TBL] [Abstract][Full Text] [Related]
11. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
12. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
Coldwell MC; Boyfield I; Brown T; Hagan JJ; Middlemiss DN
Br J Pharmacol; 1999 Aug; 127(7):1696-702. PubMed ID: 10455328
[TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression and characterization of a human dopamine D4.2 receptor (CHO K1 cells) and various D4.2/D2L chimeras (COS-7 cells).
Shih YH; Chung FZ; Pugsley TA
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):153-67. PubMed ID: 9075264
[TBL] [Abstract][Full Text] [Related]
16. A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
Sautel F; Griffon N; Lévesque D; Pilon C; Schwartz JC; Sokoloff P
Neuroreport; 1995 Jan; 6(2):329-32. PubMed ID: 7756621
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
Coldwell MC; Boyfield I; Brown AM; Stemp G; Middlemiss DN
Br J Pharmacol; 1999 Jul; 127(5):1135-44. PubMed ID: 10455259
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
[TBL] [Abstract][Full Text] [Related]
19. [3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptors.
Cussac D; Newman-Tancredi A; Sezgin L; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):569-72. PubMed ID: 10832613
[TBL] [Abstract][Full Text] [Related]
20. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
